Listen to this story
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThis audio file is brought to you by 
0:00
0:00
Loading audio file, please wait.
A Parkinson’s disease medication originally developed and sold by Eli Lilly and Co. has been voluntarily pulled from the
Pergolide, which Lilly sold under the Permax brand, has been licensed to the
The FDA concluded alternative medications called dopamine agonists are safer. The newer drugs are Mirapex, sold by Boehringer Ingelheim GmbH, and Requip, sold by GlaxoSmithKline Plc.
Please enable JavaScript to view this content.